Anc-AAV – an enabling technology for in vivo gene therapyWith gene therapies transforming human health, the demand for viral vectors has risen to unprecedented levels. Numerous clinical studies have utilized validated Adeno-associated viral vectors (AAV) as effective delivery vehicles for gene transfer. We aim to support you in using these vectors for your gene therapy applications, and can even help select the right capsid for desired properties such as target tissue specificity.
Our Anc-AAV viral vector technology platform can help evaluate multiple parameters of the large and highly diverse Anc-AAV libraries in vivo. This helps you select the best novel capsid for a given target product profile.